HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiong Huang Selected Research

repaglinide (Prandin)

9/2012NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes.
5/2012KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetic patients.
12/2010Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
6/2010IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiong Huang Research Topics

Disease

35Neoplasms (Cancer)
11/2022 - 02/2003
29Colorectal Neoplasms (Colorectal Cancer)
11/2022 - 07/2002
13Inflammation (Inflammations)
01/2022 - 03/2008
11Type 2 Diabetes Mellitus (MODY)
06/2019 - 07/2009
10Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 10/2008
9Neoplasm Metastasis (Metastasis)
04/2021 - 06/2005
9Insulin Resistance
05/2015 - 07/2009
7Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2005
7Arthritis (Polyarthritis)
01/2022 - 12/2013
7Colonic Neoplasms (Colon Cancer)
12/2008 - 07/2002
6Fibrosis (Cirrhosis)
02/2021 - 01/2018
6Rheumatoid Arthritis
11/2017 - 02/2013
6Adenoma (Adenomas)
08/2008 - 02/2003
5Cardiovascular Diseases (Cardiovascular Disease)
02/2022 - 04/2018
5Asthma (Bronchial Asthma)
11/2021 - 05/2016
5Carcinogenesis
04/2021 - 01/2004
4Psoriatic Arthritis
01/2022 - 01/2019
4Sepsis (Septicemia)
01/2021 - 01/2017
4Infections
01/2021 - 03/2016
4Hypersensitivity (Allergy)
11/2012 - 09/2009
4Adenocarcinoma
03/2007 - 01/2004
4Microsatellite Instability
01/2004 - 07/2002
3Wounds and Injuries (Trauma)
11/2020 - 08/2007
3Body Weight (Weight, Body)
01/2020 - 09/2005
3Lung Neoplasms (Lung Cancer)
12/2019 - 07/2011
3Obesity
06/2019 - 06/2007
3Hyperglycemia
02/2019 - 12/2008
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019 - 10/2017
3Diabetic Retinopathy (Retinopathy, Diabetic)
11/2018 - 12/2008
3Retinal Neovascularization
11/2018 - 03/2008
3Lymphatic Metastasis
01/2016 - 02/2003
3Immediate Hypersensitivity
04/2010 - 09/2009
3Carcinoma (Carcinomatosis)
02/2006 - 01/2004
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
02/2022 - 01/2022
2Hyperlipidemias (Hyperlipidemia)
02/2022 - 01/2022
2Hypertension (High Blood Pressure)
01/2022 - 01/2022
2Hyperthermia
01/2022 - 11/2021
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 10/2019
2Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2020
2Hypoxia (Hypoxemia)
10/2021 - 12/2019
2COVID-19
01/2021 - 06/2020
2Necrosis
01/2020 - 12/2013
2Poisoning
11/2019 - 10/2019
2Stroke (Strokes)
11/2019 - 01/2019
2Diabetic Nephropathies (Diabetic Nephropathy)
02/2019 - 01/2011
2Ischemia
01/2019 - 10/2018

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
04/2021 - 01/2004
11Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2006
10Glucose (Dextrose)FDA LinkGeneric
01/2022 - 02/2006
8Messenger RNA (mRNA)IBA
01/2014 - 02/2003
7Triglycerides (Triacylglycerol)IBA
02/2022 - 06/2010
7CholesterolIBA
02/2022 - 07/2009
7Insulin (Novolin)FDA Link
01/2020 - 07/2009
7CytokinesIBA
01/2020 - 05/2015
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2003
6Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 12/2013
6Interleukin-33IBA
11/2021 - 05/2016
6Immunoglobulin E (IgE)IBA
11/2021 - 09/2009
5Therapeutic UsesIBA
01/2022 - 06/2009
5Pharmaceutical PreparationsIBA
01/2022 - 07/2002
5Biological ProductsIBA
01/2022 - 12/2008
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 03/2008
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2022
4Oxygen (Dioxygen)IBA
01/2022 - 03/2008
4LDL CholesterolIBA
01/2022 - 06/2010
4Retinaldehyde (Retinal)IBA
11/2018 - 09/2008
4Immunoglobulin D (IgD)IBA
01/2018 - 01/2016
4repaglinide (Prandin)FDA Link
09/2012 - 06/2010
4HDL CholesterolIBA
09/2012 - 06/2010
4insulin-like growth factor binding protein-related protein 1IBA
10/2008 - 02/2003
3Indicators and Reagents (Reagents)IBA
02/2022 - 01/2004
3oxidized low density lipoproteinIBA
01/2022 - 06/2010
3LipidsIBA
01/2022 - 01/2022
3Fatty Acids (Saturated Fatty Acids)IBA
02/2021 - 01/2018
3MicroRNAs (MicroRNA)IBA
11/2019 - 12/2012
3Insulin-Like PeptidesIBA
01/2014 - 11/2006
3Rosiglitazone (Avandia)FDA Link
10/2011 - 07/2009
3beta CateninIBA
12/2008 - 01/2004
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
11/2007 - 11/2004
3SecretagoginsIBA
02/2007 - 05/2006
2DesmosterolIBA
02/2022 - 01/2022
2NitrogenIBA
01/2022 - 01/2021
2C-Reactive ProteinIBA
01/2022 - 01/2014
2Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 06/2020
2LigandsIBA
01/2022 - 12/2018
2AntigensIBA
11/2021 - 02/2018
2AdiponectinIBA
02/2021 - 07/2009
2efavirenz (Sustiva)FDA Link
12/2020 - 01/2020
2SuspensionsIBA
11/2020 - 11/2020
2OvalbuminIBA
01/2020 - 02/2018
2AntibodiesIBA
01/2020 - 12/2018
2InterferonsIBA
01/2020 - 01/2017
2CollagenIBA
01/2020 - 02/2018
2Bongkrekic AcidIBA
11/2019 - 10/2019
2NF-kappa B (NF-kB)IBA
02/2019 - 01/2017
2Amino AcidsFDA Link
01/2019 - 01/2016
2Long Noncoding RNAIBA
01/2019 - 01/2018

Therapy/Procedure

22Therapeutics
01/2022 - 10/2002
8Drug Therapy (Chemotherapy)
11/2021 - 07/2002
2Phototherapy (Light Therapy)
01/2022 - 11/2021